The highly elevated pre‐treatment NfL concentrations seen in infantile‐onset SMA are in line with previously reported levels of cNfL and NfH in plasma of treatment‐naïve SMA patients with 2 SMN2 copies.9, 10. The gene discussed is NEFL; the disease is proximal spinal muscular atrophy.